Extended Deep Learning Algorithm for Improved Brain Tumor Diagnosis System

At present,the prediction of brain tumors is performed using Machine Learning(ML)and Deep Learning(DL)algorithms.Although various ML and DL algorithms are adapted to predict brain tumors to some range,some concerns still need enhancement,particularly accuracy,sensitivity,false positive and false negative,to improve the brain tumor prediction system symmetrically.Therefore,this work proposed an Extended Deep Learning Algorithm(EDLA)to measure performance parameters such as accuracy,sensitivity,and false positive and false negative rates.In addition,these iterated measures were analyzed by comparing the EDLA method with the Convolutional Neural Network(CNN)way further using the SPSS tool,and respective graphical illustrations were shown.The results were that the mean performance measures for the proposed EDLA algorithm were calculated,and those measured were accuracy(97.665%),sensitivity(97.939%),false positive(3.012%),and false negative(3.182%)for ten iterations.Whereas in the case of the CNN,the algorithm means accuracy gained was 94.287%,mean sensitivity 95.612%,mean false positive 5.328%,and mean false negative 4.756%.These results show that the proposed EDLA method has outperformed existing algorithms,including CNN,and ensures symmetrically improved parameters.Thus EDLA algorithm introduces novelty concerning its performance and particular activation function.This proposed method will be utilized effectively in brain tumor detection in a precise and accurate manner.This algorithm would apply to brain tumor diagnosis and be involved in various medical diagnoses aftermodification.If the quantity of dataset records is enormous,then themethod’s computation power has to be updated.

Tumor necrosis factor-stimulated gene-6 ameliorates early brain injury after subarachnoid hemorrhage by suppressing NLRC4 inflammasome-mediated astrocyte pyroptosis

Subarachnoid hemorrhage is associated with high morbidity and mortality and lacks effective treatment.Pyroptosis is a crucial mechanism underlying early brain injury after subarachnoid hemorrhage.Previous studies have confirmed that tumor necrosis factor-stimulated gene-6(TSG-6)can exert a neuroprotective effect by suppressing oxidative stress and apoptosis.However,no study to date has explored whether TSG-6 can alleviate pyroptosis in early brain injury after subarachnoid hemorrhage.In this study,a C57BL/6J mouse model of subarachnoid hemorrhage was established using the endovascular perforation method.Our results indicated that TSG-6 expression was predominantly detected in astrocytes,along with NLRC4 and gasdermin-D(GSDMD).The expression of NLRC4,GSDMD and its N-terminal domain(GSDMD-N),and cleaved caspase-1 was significantly enhanced after subarachnoid hemorrhage and accompanied by brain edema and neurological impairment.To explore how TSG-6 affects pyroptosis during early brain injury after subarachnoid hemorrhage,recombinant human TSG-6 or a siRNA targeting TSG-6 was injected into the cerebral ventricles.Exogenous TSG-6 administration downregulated the expression of NLRC4 and pyroptosis-associated proteins and alleviated brain edema and neurological deficits.Moreover,TSG-6 knockdown further increased the expression of NLRC4,which was accompanied by more severe astrocyte pyroptosis.In summary,our study revealed that TSG-6 provides neuroprotection against early brain injury after subarachnoid hemorrhage by suppressing NLRC4 inflammasome activation-induced astrocyte pyroptosis.

Suppressing Wnt signaling of the blood-tumor barrier to intensify drug delivery and inhibit lipogenesis of brain metastases

Lipogenesis is often highly upregulated in breast cancer brain metastases to adapt to intracranial low lipid microenvironments.Lipase inhibitors hold therapeutic potential but their intra-tumoral distribution is often blocked by the blood-tumor barrier(BTB).BTB activates its Wnt signaling to maintain barrier properties,e.g.,Mfsd2a-mediated BTB low transcytosis.Here,we reported VCAM-1-targeting nano-wogonin(W@V-NPs)as an adjuvant of nano-orlistat(O@V-NPs)to intensify drug delivery and inhibit lipogenesis of brain metastases.W@V-NPs were proven to be able to inactivate BTB Wnt signaling,downregulate BTB Mfsd2a,accelerate BTB vesicular transport,and enhance tumor accumulation of O@V-NPs.With the ability to specifically kill cancer cells in a lipid-deprived environment with IC_(50) at 48 ng/mL,W@V-NPs plus O@V-NPs inhibited the progression of brain metastases with prolonged survival of model mice.The combination did not induce brain edema,cognitive impairment,and systemic toxicity in healthy mice.Targeting Wnt signaling could safely modulate the BTB to improve drug delivery and metabolic therapy against brain metastases.

Incidence,Risk Factors,and Prognosis of Patients with Hepatocellular Carcinoma and Brain Metastases

Objective Brain metastases significantly impact the clinical course of patients with hepatocellular carcinoma(HCC).This study aimed to examine the age-related incidence,demographics,and survival of patients with HCC and brain metastases.Methods Data of HCC patients from 2010 to 2015 in the Surveillance,Epidemiology,and End Results(SEER)Registry were screened for the presence of brain metastases.They were stratified by age and ethnicity.Multivariable logistic and Cox regression analyses were used to identify factors associated with brain metastases and those with overall survival(OS)and liver cancer-specific survival(CSS),respectively.Results A total of 141 HCC patients presenting with brain metastases were identified,accounting for 0.35% of all HCC patients and 2.37% of patients with metastatic disease.Among all HCC patients,the incidence rate was the highest among patients aged 30-49 years old(0.47%).Ethnicity was not associated with the presence of brain metastases at the time of HCC diagnosis.However,African-American patients presented with a significantly lower disease-specific survival[median time:1 month;interquartile range(IQR):0-3.0 months].Initial lung or bone metastasis was independently associated with an increased risk of the presence of brain metastases[odds ratio(OR):12.62,95% confidence interval(CI):8.40-18.97]but was not associated with a worse OS or CSS among those with brain metastases.Conclusion This study identified the age-related incidence and risk factors of brain metastases in HCC patients.These results may contribute to the consideration of brain screening among patients with initial metastatic HCC with lung or bone metastases,and influence the counseling of this patient population regarding their prognosis.

Intelligent Machine Learning Based Brain Tumor Segmentation through Multi-Layer Hybrid U-Net with CNN Feature Integration

Brain tumors are a pressing public health concern, characterized by their high mortality and morbidity rates.Nevertheless, the manual segmentation of brain tumors remains a laborious and error-prone task, necessitatingthe development of more precise and efficient methodologies. To address this formidable challenge, we proposean advanced approach for segmenting brain tumorMagnetic Resonance Imaging (MRI) images that harnesses theformidable capabilities of deep learning and convolutional neural networks (CNNs). While CNN-based methodshave displayed promise in the realm of brain tumor segmentation, the intricate nature of these tumors, markedby irregular shapes, varying sizes, uneven distribution, and limited available data, poses substantial obstacles toachieving accurate semantic segmentation. In our study, we introduce a pioneering Hybrid U-Net framework thatseamlessly integrates the U-Net and CNN architectures to surmount these challenges. Our proposed approachencompasses preprocessing steps that enhance image visualization, a customized layered U-Net model tailoredfor precise segmentation, and the inclusion of dropout layers to mitigate overfitting during the training process.Additionally, we leverage the CNN mechanism to exploit contextual information within brain tumorMRI images,resulting in a substantial enhancement in segmentation accuracy.Our experimental results attest to the exceptionalperformance of our framework, with accuracy rates surpassing 97% across diverse datasets, showcasing therobustness and effectiveness of our approach. Furthermore, we conduct a comprehensive assessment of ourmethod’s capabilities by evaluating various performance measures, including the sensitivity, Jaccard-index, andspecificity. Our proposed model achieved 99% accuracy. The implications of our findings are profound. Theproposed Hybrid U-Net model emerges as a highly promising diagnostic tool, poised to revolutionize brain tumorimage segmentation for radiologists and clinicians.

Targeting brain tumors with innovative nanocarriers:bridging the gap through the blood-brain barrier

Background:Glioblastoma multiforme(GBM)is recognized as the most lethal and most highly invasive tumor.The high likelihood of treatment failure arises fromthe presence of the blood-brain barrier(BBB)and stemcells around GBM,which avert the entry of chemotherapeutic drugs into the tumormass.Objective:Recently,several researchers have designed novel nanocarrier systems like liposomes,dendrimers,metallic nanoparticles,nanodiamonds,and nanorobot approaches,allowing drugs to infiltrate the BBB more efficiently,opening up innovative avenues to prevail over therapy problems and radiation therapy.Methods:Relevant literature for this manuscript has been collected from a comprehensive and systematic search of databases,for example,PubMed,Science Direct,Google Scholar,and others,using specific keyword combinations,including“glioblastoma,”“brain tumor,”“nanocarriers,”and several others.Conclusion:This review also provides deep insights into recent advancements in nanocarrier-based formulations and technologies for GBM management.Elucidation of various scientific advances in conjunction with encouraging findings concerning the future perspectives and challenges of nanocarriers for effective brain tumor management has also been discussed.

Multi-Level Parallel Network for Brain Tumor Segmentation

Accurate automatic segmentation of gliomas in various sub-regions,including peritumoral edema,necrotic core,and enhancing and non-enhancing tumor core from 3D multimodal MRI images,is challenging because of its highly heterogeneous appearance and shape.Deep convolution neural networks(CNNs)have recently improved glioma segmentation performance.However,extensive down-sampling such as pooling or stridden convolution in CNNs significantly decreases the initial image resolution,resulting in the loss of accurate spatial and object parts information,especially information on the small sub-region tumors,affecting segmentation performance.Hence,this paper proposes a novel multi-level parallel network comprising three different level parallel subnetworks to fully use low-level,mid-level,and high-level information and improve the performance of brain tumor segmentation.We also introduce the Combo loss function to address input class imbalance and false positives and negatives imbalance in deep learning.The proposed method is trained and validated on the BraTS 2020 training and validation dataset.On the validation dataset,ourmethod achieved a mean Dice score of 0.907,0.830,and 0.787 for the whole tumor,tumor core,and enhancing tumor core,respectively.Compared with state-of-the-art methods,the multi-level parallel network has achieved competitive results on the validation dataset.

Contrast Normalization Strategies in Brain Tumor Imaging:From Preprocessing to Classification

Cancer-related to the nervous system and brain tumors is a leading cause of mortality in various countries.Magnetic resonance imaging(MRI)and computed tomography(CT)are utilized to capture brain images.MRI plays a crucial role in the diagnosis of brain tumors and the examination of other brain disorders.Typically,manual assessment of MRI images by radiologists or experts is performed to identify brain tumors and abnormalities in the early stages for timely intervention.However,early diagnosis of brain tumors is intricate,necessitating the use of computerized methods.This research introduces an innovative approach for the automated segmentation of brain tumors and a framework for classifying different regions of brain tumors.The proposed methods consist of a pipeline with several stages:preprocessing of brain images with noise removal based on Wiener Filtering,enhancing the brain using Principal Component Analysis(PCA)to obtain well-enhanced images,and then segmenting the region of interest using the Fuzzy C-Means(FCM)clustering technique in the third step.The final step involves classification using the Support Vector Machine(SVM)classifier.The classifier is applied to various types of brain tumors,such as meningioma and pituitary tumors,utilizing the Contrast-Enhanced Magnetic Resonance Imaging(CE-MRI)database.The proposed method demonstrates significantly improved contrast and validates the effectiveness of the classification framework,achieving an average sensitivity of 0.974,specificity of 0.976,accuracy of 0.979,and a Dice Score(DSC)of 0.957.Additionally,this method exhibits a shorter processing time of 0.44 s compared to existing approaches.The performance of this method emphasizes its significance when compared to state-of-the-art methods in terms of sensitivity,specificity,accuracy,and DSC.To enhance the method further in the future,it is feasible to standardize the approach by incorporating a set of classifiers to increase the robustness of the brain classification method.

ARGA-Unet:Advanced U-net segmentation model using residual grouped convolution and attention mechanism for brain tumor MRI image segmentation

Background Magnetic resonance imaging(MRI)has played an important role in the rapid growth of medical imaging diagnostic technology,especially in the diagnosis and treatment of brain tumors owing to its non invasive characteristics and superior soft tissue contrast.However,brain tumors are characterized by high non uniformity and non-obvious boundaries in MRI images because of their invasive and highly heterogeneous nature.In addition,the labeling of tumor areas is time-consuming and laborious.Methods To address these issues,this study uses a residual grouped convolution module,convolutional block attention module,and bilinear interpolation upsampling method to improve the classical segmentation network U-net.The influence of network normalization,loss function,and network depth on segmentation performance is further considered.Results In the experiments,the Dice score of the proposed segmentation model reached 97.581%,which is 12.438%higher than that of traditional U-net,demonstrating the effective segmentation of MRI brain tumor images.Conclusions In conclusion,we use the improved U-net network to achieve a good segmentation effect of brain tumor MRI images.

L_(1)-Smooth SVM with Distributed Adaptive Proximal Stochastic Gradient Descent with Momentum for Fast Brain Tumor Detection

Brain tumors come in various types,each with distinct characteristics and treatment approaches,making manual detection a time-consuming and potentially ambiguous process.Brain tumor detection is a valuable tool for gaining a deeper understanding of tumors and improving treatment outcomes.Machine learning models have become key players in automating brain tumor detection.Gradient descent methods are the mainstream algorithms for solving machine learning models.In this paper,we propose a novel distributed proximal stochastic gradient descent approach to solve the L_(1)-Smooth Support Vector Machine(SVM)classifier for brain tumor detection.Firstly,the smooth hinge loss is introduced to be used as the loss function of SVM.It avoids the issue of nondifferentiability at the zero point encountered by the traditional hinge loss function during gradient descent optimization.Secondly,the L_(1) regularization method is employed to sparsify features and enhance the robustness of the model.Finally,adaptive proximal stochastic gradient descent(PGD)with momentum,and distributed adaptive PGDwithmomentum(DPGD)are proposed and applied to the L_(1)-Smooth SVM.Distributed computing is crucial in large-scale data analysis,with its value manifested in extending algorithms to distributed clusters,thus enabling more efficient processing ofmassive amounts of data.The DPGD algorithm leverages Spark,enabling full utilization of the computer’s multi-core resources.Due to its sparsity induced by L_(1) regularization on parameters,it exhibits significantly accelerated convergence speed.From the perspective of loss reduction,DPGD converges faster than PGD.The experimental results show that adaptive PGD withmomentumand its variants have achieved cutting-edge accuracy and efficiency in brain tumor detection.Frompre-trained models,both the PGD andDPGD outperform other models,boasting an accuracy of 95.21%.

Planning Target Volume Margin in Linac-Based Stereotactic Radiosurgery for Brain Metastases

Background: The treatment of brain metastases with radiotherapy has shifted to the use of Stereotactic Radio-surgery (SRS). The technical issue of expanding the treatment volume around the Gross Tumor Volume (GTV) is a current debate. Radiotherapy centers use variable GTV-PTV margins, ranging from one to 2 mm. Material and Methods: We performed a dosimetric comparison in plans of twenty patients using three margins: PTV zero, PTV1, and PTV2. We also developed imaginary Peel volumes. These volumes are described as follows: Peel1 = PTV1 − GTV, Peel2 = PTV2 − GTV. Results: Our results showed that the mean PTV volume differed significantly across the different margins (p = 0.000). The V12 of the brain significantly varied as a function of PTV margin (p = 0.000). The target coverage and plan quality indices were not significantly different. The Peel volume dosimetric analysis showed that the mean dose was significantly higher in the nearby normal brain tissue: Peel1 (p = 0.022) and Peel 2 (p = 0.013). Conclusion: According to our dosimetric analysis, expanding the GTV into a PTV by 1 mm margin is more convenient than 2 mm.

Transformation of MRI Images to Three-Level Color Spaces for Brain Tumor Classification Using Deep-Net

In the domain ofmedical imaging,the accurate detection and classification of brain tumors is very important.This study introduces an advanced method for identifying camouflaged brain tumors within images.Our proposed model consists of three steps:Feature extraction,feature fusion,and then classification.The core of this model revolves around a feature extraction framework that combines color-transformed images with deep learning techniques,using the ResNet50 Convolutional Neural Network(CNN)architecture.So the focus is to extract robust feature fromMRI images,particularly emphasizingweighted average features extracted fromthe first convolutional layer renowned for their discriminative power.To enhance model robustness,we introduced a novel feature fusion technique based on the Marine Predator Algorithm(MPA),inspired by the hunting behavior of marine predators and has shown promise in optimizing complex problems.The proposed methodology can accurately classify and detect brain tumors in camouflage images by combining the power of color transformations,deep learning,and feature fusion via MPA,and achieved an accuracy of 98.72%on a more complex dataset surpassing the existing state-of-the-art methods,highlighting the effectiveness of the proposed model.The importance of this research is in its potential to advance the field ofmedical image analysis,particularly in brain tumor diagnosis,where diagnoses early,and accurate classification are critical for improved patient results.

An Effective Diagnosis System for Brain Tumor Detection and Classification

A brain tumor is an excessive development of abnormal and uncontrolled cells in the brain.This growth is considered deadly since it may cause death.The brain controls numerous functions,such as memory,vision,and emotions.Due to the location,size,and shape of these tumors,their detection is a challenging and complex task.Several efforts have been conducted toward improved detection and yielded promising results and outcomes.However,the accuracy should be higher than what has been reached.This paper presents a method to detect brain tumors with high accuracy.The method works using an image segmentation technique and a classifier in MATLAB.The utilized classifier is a SupportVector Machine(SVM).DiscreteWavelet Transform(DWT)and Principal Component Analysis(PCA)are also involved.A dataset from the Kaggle website is used to test the developed approach.The obtained results reached nearly 99.2%of accuracy.The paper provides a confusion matrix of applying the proposed approach to testing images and a comparative evaluation between the developed method and some works in the literature.This evaluation shows that the presented system outperforms other approaches regarding the accuracy,precision,and recall.This research discovered that the developed method is extremely useful in detecting brain tumors,given the high accuracy,precision,and recall results.The proposed system directs us to believe that bringing this kind of technology to physicians diagnosing brain tumors is crucial.

Different types of tumor microvessels in stageⅠ-ⅢA squamous cell lung cancer and their clinical significance

BACKGROUND Lung cancer(LC)is the leading cause of morbidity and mortality among malignant neoplasms.Improving the diagnosis and treatment of LC remains an urgent task of modern oncology.Previously,we established that in gastric,breast and cervical cancer,tumor microvessels(MVs)differ in morphology and have different prognostic significance.The connection between different types of tumor MVs and the progression of LC is not well understood.AIM To evaluate the morphological features and clinical significance of tumor MVs in lung squamous cell carcinoma(LUSC).METHODS A single-center retrospective cohort study examined medical records and archival paraffin blocks of 62 and 180 patients with stage I-IIIA LUSC in the training and main cohorts,respectively.All patients underwent radical surgery(R0)at the Orenburg Regional Cancer Clinic from May/20/2009 to December/14/2021.Tumor sections were routinely processed,and routine Mayer's hematoxylin and eosin staining and immunohistochemical staining for cluster of differentiation 34(CD34),podoplanin,Snail and hypoxia-inducible factor-1 alpha were performed.The morphological features of different types of tumor MVs,tumor parenchyma and stroma were studied according to clinicopathological characteristics and LUSC prognosis.Statistical analysis was performed using Statistica 10.0 software.Univariate and multivariate logistic regression analyses were performed to identify potential risk factors for LUSC metastasis to regional lymph nodes(RLNs)and disease recurrence.Receiver operating characteristic curves were constructed to discriminate between patients with and without metastases in RLNs and those with and without disease recurrence.The effectiveness of the predictive models was assessed by the area under the curve.Survival was analyzed using the Kaplan-Meier method.The log-rank test was used to compare survival curves between patient subgroups.A value of P<0.05 was considered to indicate statistical significance.RESULTS Depending on the morphology,we classified tumor vessels into the following types:normal MVs,dilated capillaries(DCs),atypical DCs,DCs with weak expression of CD34,"contact-type"DCs,structures with partial endothelial linings,capillaries in the tumor solid component and lymphatic vessels in lymphoid and polymorphocellular infiltrates.We also evaluated the presence of loose,fine fibrous connective tissue(LFFCT)and retraction clefts in the tumor stroma,tumor spread into the alveolar air spaces(AASs)and fragmentation of the tumor solid component.According to multivariate analysis,the independent predictors of LUSC metastasis in RLNs were central tumor location(P<0.00001),the presence of retraction clefts(P=0.003),capillaries in the tumor solid component(P=0.023)and fragmentation in the tumor solid component(P=0.009),whereas the independent predictors of LUSC recurrence were tumor grade 3(G3)(P=0.001),stage N2(P=0.016),the presence of LFFCT in the tumor stroma(P<0.00001),fragmentation of the tumor solid component(P=0.0001),and the absence of tumor spread through the AASs(P=0.0083).CONCLUSION The results obtained confirm the correctness of our previously proposed classification of different types of tumor vessels and may contribute to improving the diagnosis and treatment of LUSC.

RBEBT: A ResNet-Based BA-ELM for Brain Tumor Classification

Brain tumor refers to the formation of abnormal cells in the brain.It can be divided into benign and malignant.The main diagnostic methods for brain tumors are plain X-ray film,Magnetic resonance imaging(MRI),and so on.However,these artificial diagnosis methods are easily affected by external factors.Scholars have made such impressive progress in brain tumors classification by using convolutional neural network(CNN).However,there are still some problems:(i)There are many parameters in CNN,which require much calculation.(ii)The brain tumor data sets are relatively small,which may lead to the overfitting problem in CNN.In this paper,our team proposes a novel model(RBEBT)for the automatic classification of brain tumors.We use fine-tuned ResNet18 to extract the features of brain tumor images.The RBEBT is different from the traditional CNN models in that the randomized neural network(RNN)is selected as the classifier.Meanwhile,our team selects the bat algorithm(BA)to opti7mize the parameters of RNN.We use fivefold cross-validation to verify the superiority of the RBEBT.The accuracy(ACC),specificity(SPE),precision(PRE),sensitivity(SEN),and F1-score(F1)are 99.00%,95.00%,99.00%,100.00%,and 100.00%.The classification performance of the RBEBT is greater than 95%,which can prove that the RBEBT is an effective model to classify brain tumors.

Automated Brain Tumor Diagnosis Using Deep Residual U-Net Segmentation Model

Automated segmentation and classification of biomedical images act as a vital part of the diagnosis of brain tumors(BT).A primary tumor brain analysis suggests a quicker response from treatment that utilizes for improving patient survival rate.The location and classification of BTs from huge medicinal images database,obtained from routine medical tasks with manual processes are a higher cost together in effort and time.An automatic recognition,place,and classifier process was desired and useful.This study introduces anAutomatedDeepResidualU-Net Segmentation with Classification model(ADRU-SCM)for Brain Tumor Diagnosis.The presentedADRUSCM model majorly focuses on the segmentation and classification of BT.To accomplish this,the presented ADRU-SCM model involves wiener filtering(WF)based preprocessing to eradicate the noise that exists in it.In addition,the ADRU-SCM model follows deep residual U-Net segmentation model to determine the affected brain regions.Moreover,VGG-19 model is exploited as a feature extractor.Finally,tunicate swarm optimization(TSO)with gated recurrent unit(GRU)model is applied as a classification model and the TSO algorithm effectually tunes theGRUhyperparameters.The performance validation of the ADRU-SCM model was tested utilizing FigShare dataset and the outcomes pointed out the better performance of the ADRU-SCM approach on recent approaches.

Computer-Aided Diagnosis Model Using Machine Learning for Brain Tumor Detection and Classification

The Brain Tumor(BT)is created by an uncontrollable rise of anomalous cells in brain tissue,and it consists of 2 types of cancers they are malignant and benign tumors.The benevolent BT does not affect the neighbouring healthy and normal tissue;however,the malignant could affect the adjacent brain tissues,which results in death.Initial recognition of BT is highly significant to protecting the patient’s life.Generally,the BT can be identified through the magnetic resonance imaging(MRI)scanning technique.But the radiotherapists are not offering effective tumor segmentation in MRI images because of the position and unequal shape of the tumor in the brain.Recently,ML has prevailed against standard image processing techniques.Several studies denote the superiority of machine learning(ML)techniques over standard techniques.Therefore,this study develops novel brain tumor detection and classification model using met heuristic optimization with machine learning(BTDC-MOML)model.To accomplish the detection of brain tumor effectively,a Computer-Aided Design(CAD)model using Machine Learning(ML)technique is proposed in this research manuscript.Initially,the input image pre-processing is performed using Gaborfiltering(GF)based noise removal,contrast enhancement,and skull stripping.Next,mayfly optimization with the Kapur’s thresholding based segmentation process takes place.For feature extraction proposes,local diagonal extreme patterns(LDEP)are exploited.At last,the Extreme Gradient Boosting(XGBoost)model can be used for the BT classification process.The accuracy analysis is performed in terms of Learning accuracy,and the validation accuracy is performed to determine the efficiency of the proposed research work.The experimental validation of the proposed model demonstrates its promising performance over other existing methods.

Brain Tumor:Hybrid Feature Extraction Based on UNet and 3DCNN

Automated segmentation of brain tumors using Magnetic Resonance Imaging(MRI)data is critical in the analysis and monitoring of disease development.As a result,gliomas are aggressive and diverse tumors that may be split into intra-tumoral groups by using effective and accurate segmentation methods.It is intended to extract characteristics from an image using the Gray Level Co-occurrence(GLC)matrix feature extraction method described in the proposed work.Using Convolutional Neural Networks(CNNs),which are commonly used in biomedical image segmentation,CNNs have significantly improved the precision of the state-of-the-art segmentation of a brain tumor.Using two segmentation networks,a U-Net and a 3D CNN,we present a major yet easy combinative technique that results in improved and more precise estimates.The U-Net and 3D CNN are used together in this study to get better and more accurate estimates of what is going on.Using the dataset,two models were developed and assessed to provide segmentation maps that differed fundamentally in terms of the segmented tumour sub-region.Then,the estimates was made by two separate models that were put together to produce the final prediction.In comparison to current state-of-the-art designs,the precision(percentage)was 98.35,98.5,and 99.4 on the validation set for tumor core,enhanced tumor,and whole tumor,respectively.

Brain Tumor Identification Using Data Augmentation and Transfer Learning Approach

A brain tumor is a lethal neurological disease that affects the average performance of the brain and can be fatal.In India,around 15 million cases are diagnosed yearly.To mitigate the seriousness of the tumor it is essential to diagnose at the beginning.Notwithstanding,the manual evaluation process utilizing Magnetic Resonance Imaging(MRI)causes a few worries,remarkably inefficient and inaccurate brain tumor diagnoses.Similarly,the examination process of brain tumors is intricate as they display high unbalance in nature like shape,size,appearance,and location.Therefore,a precise and expeditious prognosis of brain tumors is essential for implementing the of an implicit treatment.Several computer models adapted to diagnose the tumor,but the accuracy of the model needs to be tested.Considering all the above mentioned things,this work aims to identify the best classification system by considering the prediction accuracy out of Alex-Net,ResNet 50,and Inception V3.Data augmentation is performed on the database and fed into the three convolutions neural network(CNN)models.A comparison line is drawn between the three models based on accuracy and performance.An accuracy of 96.2%is obtained for AlexNet with augmentation and performed better than ResNet 50 and Inception V3 for the 120th epoch.With the suggested model with higher accuracy,it is highly reliable if brain tumors are diagnosed with available datasets.

Baseline radiologic features as predictors of efficacy in patients with pancreatic neuroendocrine tumors with liver metastases receiving surufatinib

Objective:Currently,pre-treatment prediction of patients with pancreatic neuroendocrine tumors with liver metastases(PNELM)receiving surufatinib treatment was unsatisfying.Our objective was to examine the association between radiological characteristics and efficacy/prognosis.Methods:We enrolled patients with liver metastases in the phase III,SANET-p trial(NCT02589821)and obtained contrast-enhanced computed tomography(CECT)images.Qualitative and quantitative parameters including hepatic tumor margins,lesion volumes,enhancement pattern,localization types,and enhancement ratios were evaluated.The progression-free survival(PFS)and hazard ratio(HR)were calculated using Cox’s proportional hazard model.Efficacy was analyzed by logistic-regression models.Results:Among 152 patients who had baseline CECT assessments and were included in this analysis,the surufatinib group showed statistically superior efficacy in terms of median PFS compared to placebo across various qualitative and quantitative parameters.In the multivariable analysis of patients receiving surufatinib(N=100),those with higher arterial phase standardized enhancement ratio-peri-lesion(ASER-peri)exhibited longer PFS[HR=0.039;95%confidence interval(95%CI):0.003−0.483;P=0.012].Furthermore,patients with a high enhancement pattern experienced an improvement in the objective response ratio[31.3%vs.14.7%,odds ratio(OR)=3.488;95%CI:1.024−11.875;P=0.046],and well-defined tumor margins were associated with a higher disease control rate(DCR)(89.3%vs.68.2%,OR=4.535;95%CI:1.285−16.011;P=0.019)compared to poorlydefined margins.Conclusions:These pre-treatment radiological features,namely high ASER-peri,high enhancement pattern,and well-defined tumor margins,have the potential to serve as predictive markers of efficacy in patients with PNELM receiving surufatinib.